In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-05-21 | Dec-31-20 | Dec-05-20 |
| 10-K | 10-K | 8-K | 10-K | 8-K |
Cash flows from operating activities: | | | | | |
Net income | | | -9.0 | | -6.7 |
Adjustments to reconcile net income to net cash from operating activities: | | | | | |
Depreciation and amortization expense | | | 18.2 | | 16.8 |
Deferred income taxes | | | -1.2 | | -2.8 |
Changes in operating assets and liabilities: | | | | | |
Prepaid expenses and other current assets | | | -4.1 | | -0.6 |
Accounts receivable, net | | | -2.2 | | -2.2 |
Unbilled receivables | | | | | |
Other assets | | | -0.9 | | -0.3 |
Accounts payable | | | -1.1 | | 1.4 |
Accrued expenses and other current liabilities | 12.0 | 8.9 | | 7.3 | |
Deferred revenue | 1.5 | 2.0 | 2.0 | 0.5 | 0.5 |
Other long-term liabilities | | | -0.7 | | 3.1 |
Net cash provided by operating activities | 52.3 | 24.4 | 24.4 | 19.6 | 19.6 |
|
Cash flows from investing activities: | | | | | |
Net cash used in investing activities | -6.5 | -4.5 | -4.5 | -30.9 | -30.9 |
|
Cash flows from financing activities: | | | | | |
Payment of debt issuance costs | 0.0 | 1.1 | -1.1 | | |
Proceeds from exercise of stock based options | 13.1 | 1.6 | | 5.0 | |
Proceeds from issuance of common stock under employee stock purchase plan | 1.0 | 1.6 | | 5.0 | |
Payment of initial public offering costs | 0.3 | 5.3 | | | |
Net cash provided by financing activities | 11.7 | 205.0 | 205.0 | 34.7 | 34.7 |
|
Reconciliation of cash, cash equivalents, and restricted cash: | | | | | |
Cash and cash equivalents | | | | | |
Restricted cash within other assets | | | | | |
Restricted Cash and Cash Equivalents, Noncurrent, Statement of Financial Position [Extensible Enumeration] | | | | | |
Supplemental cash flow information: | | | | | |
Cash paid for interest | 0.2 | 5.4 | | 5.7 | |
Cash paid for taxes | 4.5 | 0.2 | | 0.1 | |
Supplemental disclosure of non-cash transactions: | | | | | |
Additions to property and equipment included in accounts payable and accrued expenses | 0.2 | 0.2 | | 0.1 | |
Deferred initial public offering costs included in accrued expenses | | | | | |